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Studies of Multiple Endocrine Neoplasia Type 2A Syndrome: Linkage 
Analyses and Comparison of Constitutional and Tlimor Genotypes 
Hideo Tateishi, Shin-ichiro Takai,* Isamu Nishisho, Tetsuro Miki, Kazuyoshi 
Motomura, Makoto Okazaki, Akira Miyauchi, Tatsuro Ikeuchi, Kohtaro Yamamoto, 
Tatsuo Hattori, Yuichi Kumahara, Hideo Matsumoto, Tasuku Honjo, and 
Takesada Mori 
Linkage analyses were carried out in nine Japanese kindreds with multiple endocrine neoplasia type 
2A (MEN-2A) using polymorphic classical markers and DNA markers. We excluded close linkage of 
the MEN-2A gene (MEN2A) locus with Gm. JK. PGMl. and a DNA segment. D20S5. which is 
assigned to band 12 ofthe short arm of chromosome 20 (20pl2.2). Assuming that MEN2A is recessive 
at the cellular level as in retinoblastoma (RB) and Wilms' tumor (WT). comparison of constitutional 
and tumor genotypes may be useful in the search for the MEN2A locus. When DNA samples from 12 
patients with medullary thyroid carcinoma (MTC) were compared with 15 polymorphic DNA markers 
including two assigned to chromosome 20, the results were negative. Both the negative linkage data 
and the failure to find loss of heterozygosity in MTC with chromosome 20 probes suggest that MEN2A 
may not be at 20pl2.2, which was previously suggested as the site ofan inherited chromosomal 
deletion in MEN-2A. (Henry Ford Hosp MedJ 1987:35:157-60) 
Multiple endocrine neoplasia type 2A (MEN-2A) is in-herited in an autosomal dominant fashion. Babu and 
colleagues (1,2) reported a minute constitutional interstitial de-
letion in the short arm of chromosome 20, del (20) (pl2.2, 
pl2,2) and suggested that this might be the site of the MEN-2A 
gene (MEN2A), Other research groups (3-6), however, failed to 
demonstrate the deletion, and Goodfellow et al (7) excluded 
close linkage between the MEN2A locus and the D20S5 locus 
assigned to the region of 20pl2,2. 
Two possible explanations for the discrepancy between the 
cytogenetic findings by Babu et al (1) and the negative results of 
linkage analysis might be genetic heterogeneity of the MEN-2A 
syndrome or high levels of meiotic recombination between the 
two loci, MEN2A and D20S5. To investigate this further, we 
studied Japanese kindreds with MEN-2 A using two strategies, 
ie, linkage analysis with the probe pR 12.21 for the D20S5 locus, 
and comparison of constitutional and tumor genotypes with 
probes on chromosome 20. The results obtained with other 
genetic markers are also presented. 
Materials and Methods 
DNA samples 
Heparinized blood samples were obtained from 123 indi-
viduals belonging to 17 Japanese MEN-2 A kindreds, of which 
60 individuals were known to be affected. Aliquots ofblood 
were used for analyses of classical markers such as blood groups 
or enzyme polymorphisms, transformation by the Epstein-Barr 
virus to establish lymphoblastoid cell lines, and direct extraction 
of DNA (8). 
Genetic markers 
In each member of the kindred, 26 classical markers were de-
termined using the standard method by one of the authors (HM). 
These were nine blood groups: ABO, MNSs, P, Rh, Kell, Kidd 
(JK), Duffy (FY), Lutheran, and Diego; six plasma proteins: 
HP Tf, GC, Gm, Km, and PI; and 11 enzymes: ACPI, PGMl, 
ADA, PGD, ESD, GPT, GOT, PHI, LDH, UMPK, and GLO. 
Each member was also typed with polymorphic DNA markers 
by Southem blot analyses (8). 
Ttimor tissues 
Fresh medullary thyroid carcinoma (MTC) tumor tissues 
were frozen immediately at the time of surgery and kept at 
- 80°C until DNA extraction. 
Probes 
Probes to detect DNA polymorphisms were: phT-B3 (CALCI), 
pTBB-2 (HRASl), ADJ762 (D11S12), p9Fl 1 (D12S4), p7F12 
(D13S1), p9Dll (D13S2), plES (D13S4), pHUB8 (D13S5), 
pMSl-14(D15Sl), C-H800 (GHI), 12-62 (D18SI), pMSl-27 
(D20S4), pR12.21 (D20S5), and pMS3-18 (D22SI). These 
probes were kindly provided by other researchers. In addition, we 
used seven probes generated in our laboratory (8,9): OS-4 (D18S5) 
and six unassigned polymorphic DNA segments (OS-1, OS-2, OS-5, 
OS-6, OS-8, and OS-9). 
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Linkage analysis 
Nine of 17 kindreds collected contained at least one poten-
tially informative nuclear family, designated by letters A to I 
(Table 1). Individuals were classified as "affected" if they had 
been operated on for any component of MEN-2A or had high 
basal and/or stimulated levels of plasma calcitonin. Those un-
der 15 years of age were excluded. Lod scores for various values 
of recombinant fraction (6) were calculated (10). 
Results 
Linkage analyses with classical markers 
Table I summarizes lod scores for 11 classical markers. Close 
linkages were excluded for Gm and JK at 6 = 0.10, and for 
PGMl ate = 0.05. 
Linkage analyses with polymorphic DNA markers 
Table 2 summarizes lod scores for 11 polymorphic DNA 
markers. Linkage with D20S5 was excluded at 6 = 0.10. All 
nuclear families informative for D20S5 had at least one recom-
binant individual. None of the probes showed evidence of close 
linkage with MEN2A, although somewhat positive scores were 
obtained with our probe OS-2 (an unassigned DNA segment). 
Comparison of constitutional and tumor genotypes 
DNA samples from 12 patients with MTC, eight hereditary 
and four sporadic, were examined with 15 polymorphic DNA 
probes. A total of 48 tumor/blood comparisons were pos-
sible and in each case the tumor DNAs retained heterozygosity 
(Table 3). 
Discussion 
Cytogenetic studies are important in the search for the locus 
of the gene responsible for a hereditary disease, because abnor-
malities such as deletion or translocation often provide evidence 
for the location of the gene. For the MEN-2A syndrome, how-
ever, cytogenetic data are not conclusive (1-6). The altemative 
technique is linkage analysis. Many classical genetic markers 
have been excluded from linkage with MEN2A (4,11-14), and 
we have excluded close linkage with Gm, JK, and PGMl in 
Japanese kindreds. The exclusion of close linkage with Gm is 
consistent with the findings of Emmertsen et al (4) and Simpson 
(12), while exclusion of JK and PGMl is consistent with the 
results of Kmger et al (14). 
When we used restriction fragment length polymorphisms 
(RFLPs), our result for D20S5 agreed with that of Goodfellow et 
Table 1 
Lod Scores for MEN2A with the 11 Classical Genetic Polymorphisms 
0,05 0,10 
9 Values 
0,20 0,30 0,40 
Remarks* 
Kindreds 
ACPI - 1,442 -0,888 -0,388 -0,152 -0,036 A ( 2 , l ) ( l , l ) 
ADA ^1,185 -0,673 -0,254 -0,087 -0,018 B (4,2) 
ESD -1.442 -0,887 -0,388 -0,151 -0,035 B (3,2) 
Gm -4,181 -2,187 -0,633 -0,117 0,002 A (2,1) (1,1), B (2,1) (5,1), C (2,0), 
D(2,0)(1,1),E(4,2)(1,1) 
GOT 0,258 0,215 0,134 0,064 0,017 D (2,0) 
GPT - 1,184 -0,673 -0,254 -0,088 -0,019 C (2,1), E (2,1) (2,0) 
HP -0,188 0,021 0,124 0,094 0,031 A(3,0),B(1,1) 
JK -5,048 -3,106 -1,358 -0,530 -0,124 B (2,1) (3,3), D (1,1), E (3,2) 
MNSs -1.442 -0,888 -0,388 -0,152 -0,036 A(2,1) (1,1) 
PGMl -2,833 - 1,575 -0,568 -0,186 -0,037 B(4,2), D(1,1),E(4,2)(2,0) 
PI -0,628 -0,168 0,129 0,146 0,058 B (2,1) (5,1) 
*Lod scores were calculated from kindreds indicated here 
recombinant offspring in each nuclear family. 
Figures in the parentheses indicate the number of nonrecombinant. 
Table 2 
Lod Scores for MEN2A with the DNA Polymorphisms 
Chromosome* 0,05 0,10 
e Values 
0,20 0,30 0,40 
Remarkst 
Kindreds 
CALCl (11) 0,258 0,215 0,134 0,064 0,017 E (2,0) 
D12S4 (12) -0,463 -0,229 -0,060 -0,012 -0,001 A (2,1), D (2,0) 
D13SI (13) - 1,442 -0,888 -0,388 -0.152 -0,036 A(1,1),D(1,1) 
D13S2 (13) -0,206 -0,014 0,074 0,053 0,016 B(3,l), D(2,0) 
GH (17) 0,258 0,215 0,134 0,064 0,017 D (2,0) 
DI8S5 (18) -0,205 -0,014 0,074 0,052 0,016 A(2,0),D(2,0),F(1,1) 
D20S5 (20) -3,605 -2,220 -0,970 -0,380 -0,090 A(2,1),B(2,1),D(1,1),F(1,1),G(2,1) 
OS-1 (?) - 1,442 -0,888 -0,388 -0,152 -0,036 A(1,1),D(1,1) 
OS-2 C'I 
(?) 
0,140 0,472 0,516 0,316 0,096 A (3,0) (2,0), B (3,0) (1,1), D (2,0), G (2,1) 
OS-5 -1,389 -0,687 -0,180 -0,036 -0,003 A (1,1) (2,1), D (2,0), E (1,1), H (2,0), I (2,0) 
OS-6 (?) -0,463 -0,229 -0,060 -0,012 -0,001 F (2,0), 1(2,1) 
*The chromosome to which the DNA segment has been assigned, 
tSee Table 1. 
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al (7). This indicates no close linkage of this locus with MEN2A 
not only in Caucasian but also in Japanese families. Moreover, 
we observed at least one recombinant person in each of the 
five nuclear families informative for D20S5. Thus it is unlikely 
that genetic heterogeneity is masking a close linkage between 
D20S5 and MEN2A in a few families. 
MEN-2A has features in common with familial retinoblastoma 
(RB) and Wilms' tumor (WT). The pattem of inheritance is auto-
somal dominant, the tumors are usually multicentric and bilateral, 
and pheochromocytomas are associated with MTC in MEN-2A as 
osteosarcomas are associated with RB. Therefore, it is reasonable 
to assume that the tumors in MEN-2A might develop through the 
same genetic mechanisms as in RB or WT. 
The gene responsible for RB was found to be recessive at the 
cellular level, ie, the elimination of normal activities of both ma-
temal and patemal alleles at the disease locus seemed necessary 
for tumorigenesis (15). This theory was induced from the obser-
vation of frequent loss of heterozygosity in the tumor DNA of 
the constitutionally heterozygous patients with sporadic or 
hereditary retinoblastoma. Polymorphic DNA probes on chro-
mosome 13 were used to study the genotypes, because the RB 
gene had been assigned to the long arm of chromosome 13 (13ql4) 
cytogenetically (16). Loss of heterozygosity for chromosome 13 
probes was also demonstrated in osteosarcomas with or without RB 
(17,18). Similar results were also reported for sporadic WT (19-22) 
and sporadic or hereditary acoustic neuromas (AN) (23), with 
probes on chromosome 11 and 22, respectively. 
These findings can be assembled into the following hypoth-
eses; 1) autosomal dominant hereditary tumors result from loss 
of both copies of a gene at a single locus by either structural 
changes or deletion; 2) the same gene is involved in both heredi-
tary and sporadic tumors; and 3) the second tumor, which is 
often associated with a hereditary tumor such as osteosarcoma 
in RB, rhabdomyosarcoma in WT, or meningioma in AN, arises 
through the same mechanism involving the same or adjacent 
gene as for the first tumor. 
If these hypotheses are applicable to MEN-2A, the com-
parison of constitutional and tumor genotypes may provide a 
useful clue to the chromosomal location of the MEN-2A gene. 
For this reason we searched for loss of constitutional hetero-
zygosity in DNA from 12 MTC tumors but without positive 
results so far (Table 3). It is noteworthy that probes on the chro-
mosome 20 did not detect loss of heterozygosity in the tumor 
DNA in any of the seven informative cases (Table 3). From these 
findings combined with the data from linkage analysis, we 
conclude that it is unlikely that MEN2A is on the short arm of 
chromosome 20. 
Wurster-Hill et al (24) reported that the loss or stmctural al-
teration of a chromosome 22 was the only change common to 
each of three MTC specimens. Comparison of constitutional and 
tumor genotypes in MTC and/or pheochromocytoma as well as 
linkage analysis of MEN-2A kindreds should be carried out 
using probes on chromosome 22. 
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